Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.
23h
Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback